Miami Cancer Institute to Present Latest Radiation Oncology Research at 2022 ASTRO Annual Meeting
MIAMI, FL, & SAN ANTONIO, TX – October 24, 2022 –Miami Cancer Institute, part of Baptist Health Cancer Care, the largest cancer program in South Florida, today announced its roster of presentations at this year’s annual meeting of the American Society for Radiation Oncology (ASTRO), October 23-26, at the Henry B. Gonzalez Convention Center in San Antonio Texas. Oral and poster presentations include a wide variety of leading-edge research in the field or radiation oncology, including findings on hippocampal atrophy after radiotherapy, GI cancer outcomes, gross tumor volume as a predictive biomarker of treatment response, and the management of implantable devices in patients receiving MR-guided radiotherapy, among others.
“I am very pleased with the quality of the presentations our Miami Cancer Institute investigators are giving at this year’s ASTRO meeting,” said Minesh P. Mehta, M.D.,
deputy director of the Miami Cancer Institute and chief of radiation oncology. “The clinical trials my colleagues and I have been leading and participating in have the potential to positively impact the course of radiation therapy for cancer patients across the globe. We’re thrilled to be able to share our findings with the larger rad-onc community.”
The Miami Cancer Institute’s presentations this year include:
Oral Presentations
Monday, October 24, 2022
GI Cancers: ReSPECTing Liver Function and a Deep Dive into Esophageal Cancer Outcomes
Moderator: Michael David Chuong, M.D.
Time: 10:45 a.m. CDT
Location: Room 304
Does Hippocampal Atrophy Correlate with Neurocognitive Outcomes One Year Following Radiotherapy? Results from a Prospective Trial
Presenter: Matthew D. Hall, M.D., MBA
Time: 11:10 a.m. CDT
Location: Room 303
Tuesday, October 25, 2022
Longitudinal Assessment of Gross Tumor Volume in Abdominal and Pelvic Patients Undergoing MR-Guided Online Adaptive Radiotherapy as a Predictive Biomarker of Treatment Response
Presenter: Kathryn E. Mittauer, Ph.D.
Time: 5:15 p.m. CDT
Location: Room 214
Wednesday, October 26, 2022
Management of Cardiac Implantable Electronic Devices for Patients Receiving MR-Guided Radiotherapy: 4-Year Single Institution Experience
Presenter: James McCulloch, DMP
Time: 11 a.m. CDT
Location: Room 007 C/D
Poster Presentations
Monday, October 24, 2022
Dedicated Isotropic 3-D T1 SPACE Sequence Imaging for Radiosurgery Planning Improves Brain Metastases Detection and Reduces the Risk of Intracranial Relapse
Presenter: Tugce Kutuk, M.D.
Number: 2124
Time: 10:45 a.m. CDT
Location: Exhibit Hall 1
Pulsed Reduced Dose Rate (PRDR) Intensity Modulated Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
Presenter: Tugce Kutuk, M.D.
Number: 2161
Time: 10:45 a.m. CDT
Location: Exhibit Hall 1
The Impact of Thyroid Gland Volume on the Risk of Developing Post-RT Hypothyroidism in Breast Cancer Patients Requiring Comprehensive Nodal Irradiation
Presenter: Marcio A. Fagundes, M.D.
Number: 2086
Time: 3:00 p.m. CDT
Location: Exhibit Hall 1
Tuesday, October 25, 2022
Feasibility and Initial Results of a Daily Wearable Patient-Tracking Device for Optimization of Radiation Machine Utilization and Timely Treatment Delivery
Presenter: Adeel Kaiser, M.D.
Number: 2242
Time: 4:00 p.m. CDT
Location: Exhibit Hall 1
Wednesday, October 26, 2022
Impact of Treatment Modality on Post-Radiation Imaging in Post-Operative Head and Neck Cancers
Presenter: Edgar Gelover Reyes, Ph.D.
Number: 2686
Time: 10:30 a.m. CDT
Location: Exhibit Hall 1
An Optimal Solution Study on a Non-Invasive Stereotactic Radiosurgery Instrument Optimizer for Stereotactic Radiosurgery of Single Brain Metastasis
Presenter: Yongsook Lee, Ph.D.
Number: 3304
Time: 12:30 p.m. CDT
Location: Exhibit Hall 1
Evaluation of Pulsed Reduced Dose Rate (PRDR) Intensity Modulated Proton Therapy (IMPT) for Re-Irradiation of CNS Malignancies
Presenter: Andrew Wroe, Ph.D.
Number: 3208
Time: 12:30 p.m. CDT
Location: Exhibit Hall 1
For updates from the ASTRO Annual Meeting, look for #ASTRO22 on social media and follow Miami Cancer Institute on Twitter at @MiamiCancerIns.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
###
